https://www.regmednet.com/first-engineered-t-cell-therapy-approved-for-solid-tumors/
FDA approval after the first cohort in the Phase 2 trial.
why is this important?
- T cell therapy is a slight variant to the car T cell therapies being developed by CHM
- therapy was successful against solid tumours
- first ever fda approved t call therapy for solid tumours
Chimeric: Media Thread, page-833
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable